Emerging and re-emerging diseases in Latin America:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Saunders
2000
|
| Schriftenreihe: | Infectious disease clinics of North America
14,1 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIV, 263 S.: Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013106244 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 000413s2000 |||| 00||| eng d | ||
| 035 | |a (OCoLC)43619105 | ||
| 035 | |a (DE-599)BVBBV013106244 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-578 | ||
| 050 | 0 | |a RC109 | |
| 245 | 1 | 0 | |a Emerging and re-emerging diseases in Latin America |c Eduardo Gotuzzo, ..., guest ed. |
| 264 | 1 | |a Philadelphia [u.a.] |b Saunders |c 2000 | |
| 300 | |a XIV, 263 S.: Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Infectious disease clinics of North America |v 14,1 | |
| 650 | 2 | |a Maladies transmissibles - Épidémiologie | |
| 650 | 2 | |a Médecine tropicale | |
| 650 | 4 | |a Communicable Diseases |x epidemiology | |
| 650 | 4 | |a Communicable Diseases |z Latin America | |
| 650 | 4 | |a Cysticercosis | |
| 650 | 4 | |a Leptospirosis | |
| 650 | 4 | |a Tropical Medicine | |
| 650 | 0 | 7 | |a Infektionskrankheit |0 (DE-588)4026879-2 |2 gnd |9 rswk-swf |
| 651 | 4 | |a Lateinamerika | |
| 651 | 7 | |a Lateinamerika |0 (DE-588)4074032-8 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Lateinamerika |0 (DE-588)4074032-8 |D g |
| 689 | 0 | 1 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Gotuzzo, Eduardo |e Sonstige |4 oth | |
| 830 | 0 | |a Infectious disease clinics of North America |v 14,1 |w (DE-604)BV000841738 |9 14,1 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008928784&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008928784 | ||
Datensatz im Suchindex
| _version_ | 1804127804289187840 |
|---|---|
| adam_text | IMhKUNC. WO KI I MN U t; MSI.NSIS IN I.AIIN AMIiKk A
CONTENTS
Preface xiii
Raul Istiiriz and Eduardo Gotuzzo
Bartonellosis: New and Old 1
Ciro Maguina and Eduardo Gotuzzo
The number of species that comprise the family of Bartonellaceae,
genus Bartonella, has recently increased from one to 11 species,
five of which have been associated with different diseases and
syndromes in humans. The rapidly growing number of human
pathogens has led several investigators to regard bartonellosis
and other associated syndromes as important emerging infectious
diseases. This article presents the history and epidemiology, clini¬
cal features, diagnosis, and treatment of bartonellosis and asso¬
ciated diseases, including Carrion s disease, trench fever, endo¬
carditis and bacteremia, bacillary angiomatosis, and cat scratch
disease.
Leptospirosis in Latin America 23
Andre V. Lomar, Decio Diament, and Jaime R. Torres
Leptospirosis is a common disease in Latin America. Transmis¬
sion to humans occurs by contact with water or soil contaminated
with the urine of rodents, dogs, or livestock. Pathogenesis is still
poorly understood, and bacterial toxin or virulence factors are
probably responsible for many features of the disease. The anic
teric form is the most frequent presentation, and its clinical pic¬
ture resembles influenza or other acute febrile diseases. Ictero
hemorrhagic leptospirosis, or Weil s syndrome, represents the
severe form of the disease. Its clinical picture is similar to bacterial
sepsis and multiple organ involvement occurs, mainly in kidneys
and lungs, and causes great morbidity and mortality. Death is
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
VOLUME 14 • NUMBER 1 • MARCH 2000 vii
often related to multiple organ failure and pulmonary hemor¬
rhages. Diagnosis is based on serology or blood, cerebrospinal
fluid and urine cultures in specific media. Treatment involves a
combination of antibiotics and supportive measures.
Shigella and Shiga Toxin producing Escherichia coli
Causing Bloody Diarrhea in Latin America 41
Eduardo L. Lopez, Valeria Prado Jimenez,
Miguel O Ryan Gallardo, and Mara M. Contrini
In Latin America, Shigella and shiga toxin producing Escherichia
coli are the two leading agents in the cause of bloody diarrhea.
The already high and increasing antimicrobial resistance of Shi¬
gella also is a significant problem. Shiga toxin producing E. coli
is an emerging disease with life threatening complications: hemo
lytic uremic syndrome. Although E. coli O157:H7 remains the
most commonly recognized serotype, recently emerging, non
0157 bacteria may be the cause of a similar spectrum of disease
in humans.
Bacterial Resistance to Antimicrobial Agents in Latin
America: The Giant is Awakening 67
Manuel Guzman Bianco, Jose Maria Casellas, and
Helio Silva Sader
Resistant bacteria are emerging in Latin America as a real threat
to the favorable outcome of infections in community and hospi¬
tal acquired infections. Despite present extensive surveillance,
healthcare workers who most need the information may be un¬
aware of this growing problem. Outbreaks of meningococci with
diminished susceptibility to penicillin have been reported in the
region; a constant increase of resistance to penicillin in pneumo
cocci and poor activity of commonly used oral antibiotics for the
treatment of community acquired urinary tract infections have
made the treatment of these infections more difficult. Reports
from tertiary hospitals are similar to many other areas of the
world, with increasing frequency of Klebsiella pneumoniae cearying
extended spectrum (3 lactamase, multiresistant strains of Pseudo
monas aeruginosa and Acinetobacter baumanni in ICU settings, and
reports of methicillin resistant Staphylococcus aureus and vancomy
dn resistant enterococci. A surveillance network readily accessi¬
ble to those who prescribe antibiotics in Latin America is highly
desirable.
Plasmodiutn falciparum Infection in the Pregnant
Patient 83
Wilson D. Alecrim, Flor Ernestina M. Espinosa, and
Maria Graca C. Alecrim
Malaria should be considered a risk factor in women who are
pregnant, principally when the infection is Plasmodiutn falciparum.
Viii CONTENTS
Moreover, the risk is greater if the woman is pregnant for the
first time; if she has no immunity for malaria; if the diagnosis is
made late; or if P. falciparum shows resistance to antimalarial
drugs. This article presents the most significant aspects of P.
falciparum. malaria during pregnancy, including information about
treatments and prophylaxis.
Taenia soliutn Cysticercosis 97
Hector H. Garcia and Oscar H. Del Brutto
Cysticercosis, the infection of the larval tissue stage of the pork
tapeworm, Taenia solium, is endemic to most developing countries
and increasingly is seen in industrialized countries because of
immigration. Human infection is a major cause of acquired epi¬
lepsy, and porcine infection causes important economic losses to
farm workers. Clinical manifestations vary because of the variable
number, size, and location of the cysts and the immune response
of the host. Diagnosis is based on imaging techniques (CT and
MR imaging) and serology (immunoblot). Current research efforts
are centered on control and eradication of the taeniasis cysticer¬
cosis complex in endemic areas.
Dengue and Dengue Hemorrhagic Fever in Latin
America and the Caribbean . 121
Raul E. Isturiz, Duane J. Gubler, and Jose Brea del Castillo
Four serotypes of dengue viruses produce dengue fever, dengue
hemorrhagic fever, and dengue shock syndrome. They are the
most important arbovirus infections of humans, in terms of both
morbidity and mortality, constituting one of the most rapidly
expanding and re emerging infectious disease problems in Latin
America. In less than 20 years, the region has transformed itself
from hypoendemic to hyperendemic, while serotype circulation
in most countries has gone from none or single to multiple.
Changes in endemicity have coincided with the emergence and
increasing incidence of the severer forms of dengue infection.
This article reviews the clinical presentations of these diseases.
Health care providers who see patients in or returning from areas
of Latin America, the Caribbean, and other tropical areas must
consider dengue in the differential diagnosis of patients pre¬
senting with compatible symptoms, and must be knowledgeable
in the current management of this important disease.
Influenza 141
Daniel Stamboulian, Pablo E. Bonvehi,
Francisco M. Nacinovich, and Nancy Cox
Influenza viruses are able to emerge or re emerge as new vi¬
ruses with the potential to cause worldwide epidemics of influ¬
enza. Global surveillance is of critical importance. The clinical
CONTENTS IX
spectrum of influenza varies from asymptomatic infection to the
classical flu syndrome. Vaccination is the most effective measure
for reducing the impact of the disease, and experiences such as
the Argentinian National Immunization Campaigns provide a
model of massive vaccine administration for other Latin Ameri¬
can countries. New antivirals such as neuraminidase inhibitors
will offer valuable benefits in the prevention and treatment of
influenza.
Rodent Borne Emerging Viral Zoonosis: Hemorrhagic
Fevers and Hantavirus Infections in South America 167
Delia Enria and Francisco Pinheiro
Hantaviruses and arenaviruses are naturally occurring viruses
of rodents. Four South American hemorrhagic fevers caused by
arenaviruses have emerged in the last 5 decades. All have similar
clinical manifestations, with a case fatality rate as high as 15% to
30%. Hantavirus infections have been increasingly recognized
in South America since the description in 1993 of Hantavirus
pulmonary syndrome. Given the diversity of rodent species in
the region, it can be foreseen that many other viruses will be
discovered, and some of them will be causing human illnesses of
high public health impact.
AIDS in Latin America 185
Pedro Cahn, Waldo H. Belloso, Jorge Murillo, and
Guillermo Prada Trujillo
The HIV AIDS epidemic in Latin America has produced an unex¬
pected additional burden to health care systems and national
economies already weak and affected by severe problems. Specific
regional diseases, such as Chagas disease, leishmaniasis, and
histoplasmosis, in addition to common opportunistic infections,
and particularly the high incidence of tuberculosis, produce a
slightly different epidemiologic picture compared with the United
States and Europe. Access to antiretrovirals is not universal in
Latin America. Nevertheless, some countries are providing highly
active antiretroviral therapy to all eligible patients, showing that
it is not impossible to improve the quality of care for people
living with AIDS in the region. Drug interactions between antiret¬
rovirals and specific treatments for regional diseases generate
additional concerns for the already complex picture of the HIV
AIDS epidemic in the region.
HTLV 1 in Latin America 211
Eduardo Gotuzzo, Cesar Arango,
Abelardo de Queiroz Campos, and Raul Isturiz
HTLV l infection is endemic in several Latin American coun¬
tries. HTLV 1 associated myelophathy/ tropical spastic paraparesis
(HAM/TSP) and adult T cell leukemia lymphoma (ATLL) are
X CONTENTS
emerging diseases in the region. Documented risk factors for
acquiring the virus include breast feeding, contaminated blood
transfusion, and sexual intercourse, all of which are amenable to
prevention efforts. Strongyloides stercoralis hyperinfection syn¬
drome and therapeutic failure in apparently healthy patients with
nondisseminated strongyloidiasis may be markers of HTLV 1 in¬
fection. HTLV 1 co infection may adversely effect the clinical
course of scabies and HIV disease. The new enzyme linked im
munosorbent assays (ELISA) are sensitive and specific, and West¬
ern blot technology is reliable for differentiating HTLV 1 from
less common HTLV 2. HTLV 1 screening of blood donors and
individuals with any disorder that suggests infection has become
a necessity in Latin America to prevent the spread of this im¬
portant emerging pathogen.
State of Immunization in the Americas 241
Ciro A. de Quadras, Gina Tambini, Jose Luis DiFabio,
Monica Brana, and Jose Ignado Santos
Countries in the Americas have led the world in conquering
infectious diseases preventable through vaccination. In 1971, the
Western hemisphere achieved smallpox eradication. In 1991, the
Americas were free of indigenous transmission of wild poliovirus.
In 1998, overall regional vaccination coverage was 86% for diph
theria pertussis tetanus, 89% for oral poliovirus vaccine 3, 98%
for bacille Calmette Guerin vaccine, and 85% for measles. These
figures confirm that most of the children in the Americas are
protected against these diseases. The breakthroughs obtained in
immunization have stimulated countries to promote new initia¬
tives aimed at the control and eradication of other vaccine pre¬
ventable diseases and to introduce new vaccines into routine
schedules. In the 2lst century, vaccines will remain the most cost
effective means of preventing diseases and avoiding expensive
treatment costs.
Index 259
Subscription Information Inside back cover
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV013106244 |
| callnumber-first | R - Medicine |
| callnumber-label | RC109 |
| callnumber-raw | RC109 |
| callnumber-search | RC109 |
| callnumber-sort | RC 3109 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)43619105 (DE-599)BVBBV013106244 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01794nam a2200457 cb4500</leader><controlfield tag="001">BV013106244</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000413s2000 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)43619105</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013106244</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC109</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Emerging and re-emerging diseases in Latin America</subfield><subfield code="c">Eduardo Gotuzzo, ..., guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 263 S.: Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Infectious disease clinics of North America</subfield><subfield code="v">14,1</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Maladies transmissibles - Épidémiologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Médecine tropicale</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases</subfield><subfield code="x">epidemiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases</subfield><subfield code="z">Latin America</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cysticercosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leptospirosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tropical Medicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Lateinamerika</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Lateinamerika</subfield><subfield code="0">(DE-588)4074032-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lateinamerika</subfield><subfield code="0">(DE-588)4074032-8</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gotuzzo, Eduardo</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Infectious disease clinics of North America</subfield><subfield code="v">14,1</subfield><subfield code="w">(DE-604)BV000841738</subfield><subfield code="9">14,1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008928784&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008928784</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| geographic | Lateinamerika Lateinamerika (DE-588)4074032-8 gnd |
| geographic_facet | Lateinamerika |
| id | DE-604.BV013106244 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:39:10Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008928784 |
| oclc_num | 43619105 |
| open_access_boolean | |
| owner | DE-12 DE-578 |
| owner_facet | DE-12 DE-578 |
| physical | XIV, 263 S.: Ill., graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Saunders |
| record_format | marc |
| series | Infectious disease clinics of North America |
| series2 | Infectious disease clinics of North America |
| spelling | Emerging and re-emerging diseases in Latin America Eduardo Gotuzzo, ..., guest ed. Philadelphia [u.a.] Saunders 2000 XIV, 263 S.: Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Infectious disease clinics of North America 14,1 Maladies transmissibles - Épidémiologie Médecine tropicale Communicable Diseases epidemiology Communicable Diseases Latin America Cysticercosis Leptospirosis Tropical Medicine Infektionskrankheit (DE-588)4026879-2 gnd rswk-swf Lateinamerika Lateinamerika (DE-588)4074032-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Lateinamerika (DE-588)4074032-8 g Infektionskrankheit (DE-588)4026879-2 s DE-604 Gotuzzo, Eduardo Sonstige oth Infectious disease clinics of North America 14,1 (DE-604)BV000841738 14,1 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008928784&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Emerging and re-emerging diseases in Latin America Infectious disease clinics of North America Maladies transmissibles - Épidémiologie Médecine tropicale Communicable Diseases epidemiology Communicable Diseases Latin America Cysticercosis Leptospirosis Tropical Medicine Infektionskrankheit (DE-588)4026879-2 gnd |
| subject_GND | (DE-588)4026879-2 (DE-588)4074032-8 (DE-588)4143413-4 |
| title | Emerging and re-emerging diseases in Latin America |
| title_auth | Emerging and re-emerging diseases in Latin America |
| title_exact_search | Emerging and re-emerging diseases in Latin America |
| title_full | Emerging and re-emerging diseases in Latin America Eduardo Gotuzzo, ..., guest ed. |
| title_fullStr | Emerging and re-emerging diseases in Latin America Eduardo Gotuzzo, ..., guest ed. |
| title_full_unstemmed | Emerging and re-emerging diseases in Latin America Eduardo Gotuzzo, ..., guest ed. |
| title_short | Emerging and re-emerging diseases in Latin America |
| title_sort | emerging and re emerging diseases in latin america |
| topic | Maladies transmissibles - Épidémiologie Médecine tropicale Communicable Diseases epidemiology Communicable Diseases Latin America Cysticercosis Leptospirosis Tropical Medicine Infektionskrankheit (DE-588)4026879-2 gnd |
| topic_facet | Maladies transmissibles - Épidémiologie Médecine tropicale Communicable Diseases epidemiology Communicable Diseases Latin America Cysticercosis Leptospirosis Tropical Medicine Infektionskrankheit Lateinamerika Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008928784&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000841738 |
| work_keys_str_mv | AT gotuzzoeduardo emergingandreemergingdiseasesinlatinamerica |